Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
APA InstituteFull Access

INDUSTRY-SUPPORTED LUNCH AND DINNER SYMPOSIA OCTOBER 6-8, 2004

Published Online:20 Aug 2004https://doi.org/10.1176/pn.39.16.0390020b

Wednesday, October 6

7 p.m.-10 p.m.

The Role of Race and Ethnicity in Utilizing Atypical Antipsychotics

Chair: Henry Nasrallah, M.D.

Supported by AstraZeneca

Thursday, October 7

Noon-1:30 p.m.

Depression: Is Recovery an Achievable Goal? Part I

Chair: David Kupfer, M.D.

Supported by Eli Lilly and Company

Optimizing Patient Outcomes: Advances in the Use of Antipsychotics

Chair: Charles L. Bowden, M.D.

Supported by Pfizer

6 p.m.-9 p.m.

Covering the Bases for Supporting Bipolar Patients

Chair: Alan C. Swan, M.D.

Supported by GlaxoSmithKline

Friday, October 8

Noon-1:30 p.m.

Depression: Is Recovery an Achievable Goal? Part II

Chair: David Kupfer, M.D.

Supported by Eli Lilly and Company

Differential Diagnosis: A Different Approach to Insomnia

Chair: Ruth Benca, M.D.

Supported by King Pharmaceuticals

6 p.m.-9 p.m.

Beyond Sleep Onset: New Perspectives on the Treatment of Insomnia

Chair: Andrew Krystal, M.D.

Supported by Sepracor